Related Experiment Video
Updated: Sep 4, 2025

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
Published on: May 23, 2025
Platelets Inhibit Methicillin-Resistant Staphylococcus aureus by Inducing Hydroxyl Radical-Mediated Apoptosis-Like
Erxiong Liu1, Yutong Chen1, Jinmei Xu1
1Department of Transfusion Medicine, Xijing Hospital, Fourth Military Medical University, Xi'an, Shanxi, China.
Abstract:
Methicillin-resistant Staphylococcus aureus (MRSA) is one of the most common drug-resistant bacteria and poses a significant threat to human health. Due to the emergence of multidrug resistance, limited drugs are available for the treatment of MRSA infections. In recent years, platelets have been reported to play important roles in inflammation and immune responses, in addition to their functions in blood hemostasis and clotting. We and other researchers have previously reported that platelets can inhibit Staphylococcus aureus growth. However, it remained unclear whether platelets have the same antibacterial effect on drug-resistant strains. In this study, we hypothesized that platelets may also inhibit the growth of MRSA; the results confirmed that platelets significantly inhibited the growth of MRSA in vitro. In a murine model of MRSA infection, we found that a platelet transfusion alleviated the symptoms of MRSA infection; in contrast, depletion of platelets aggravated infective symptoms. Moreover, we observed an overproduction of hydroxyl radicals in MRSA following platelet treatment, which induced apoptosis-like death of MRSA. Our findings demonstrate that platelets can inhibit MRSA growth by promoting the overproduction of hydroxyl radicals and inducing apoptosis-like death. IMPORTANCE The widespread use of antibiotics has led to the emergence of drug-resistant bacteria, particularly multidrug-resistant bacteria. MRSA is the most common drug-resistant bacterium that causes suppurative infections in humans. As only a limited number of drugs are available to treat the infections caused by drug-resistant pathogens, it is imperative to develop novel and effective biological agents for treating MRSA infections. This is the first study to show that platelets can inhibit MRSA growth in vitro and in vivo. Our results revealed that platelets enhanced the production of hydroxyl radicals in MRSA, which induced a series of apoptosis hallmarks in MRSA, including DNA fragmentation, chromosome condensation, phosphatidylserine exposure, membrane potential depolarization, and increased intracellular caspase activity. These findings may further our understanding of platelet function.
Insights
Platelets significantly inhibit methicillin-resistant Staphylococcus aureus (MRSA) growth by inducing hydroxyl radical overproduction and apoptosis-like death. This study demonstrates platelets
Area of Science:
- Microbiology
- Immunology
- Hematology
Background:
- Methicillin-resistant Staphylococcus aureus (MRSA) is a major multidrug-resistant pathogen causing significant human health threats.
- Limited therapeutic options exist for MRSA infections due to widespread antibiotic resistance.
- Platelets, traditionally known for hemostasis, exhibit roles in inflammation and immune responses.
Purpose of the Study:
- To investigate the potential inhibitory effect of platelets on the growth of drug-resistant MRSA.
- To elucidate the mechanisms underlying platelet-mediated MRSA growth inhibition.
Main Methods:
- In vitro assessment of platelet effects on MRSA growth.
- In vivo murine model of MRSA infection with platelet transfusion and depletion.
- Analysis of hydroxyl radical production and MRSA apoptosis markers post-platelet treatment.
Main Results:
- Platelets significantly inhibited MRSA growth in vitro.
- Platelet transfusion alleviated MRSA infection symptoms in vivo, while depletion aggravated them.
- Platelet treatment induced hydroxyl radical overproduction in MRSA, leading to apoptosis-like death.
Conclusions:
- Platelets possess potent antibacterial activity against MRSA.
- Platelet-mediated inhibition of MRSA involves enhanced hydroxyl radical production and induction of apoptosis.
- Platelets represent a promising novel therapeutic agent for combating MRSA infections.
More Related Videos
05:49Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets
Published on: November 29, 2024
12:27Quantifying the Cytotoxicity of Staphylococcus aureus Against Human Polymorphonuclear Leukocytes
Published on: January 3, 2020
Related Concept Videos
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Structure and Function of Platelets
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Phagocytosis of Apoptotic Cells
Normal cells contain receptors that prevent them from being recognized...